Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases
1 other identifier
observational
1,255
1 country
12
Brief Summary
Relying on fever clinics, this project evaluates the clinical diagnostic efficiency of the three-level pathogen diagnostic system, monitors changes in respiratory pathogens, and realizes real-time monitoring and early warning of acute respiratory infectious diseases in Shanghai.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
July 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
ExpectedJuly 28, 2023
July 1, 2023
1 year
July 20, 2023
July 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
the detectioin rate of pathogenic microorganism in each step
the detectioin rate of pathogenic microorganism in each step
48 hours
Secondary Outcomes (2)
hospitalization rate
48 hours
rate of critical illness
48 hours
Eligibility Criteria
this study enrolled patients who were admitted to the fever clinics and emergency room for influenza-like illness or pneumonia and pathogenic detection was necessary for clincial diagnosis and treatment.
You may qualify if:
- Acute onset within one week;
- years old;
- Present with pneumonia (present with pulmonary signs or radiological changes) or influenza-like illness (including the following symptoms: sudden onset of fever (\>38 ℃),plus cough and/or other respiratory symptoms such as shortness of breath plus one or more systemic symptoms (fatigue, headache ect.))
You may not qualify if:
- Unable to collect nasal/nasopharyngeal swab/wash/aspirate due to structural disorder or mental problem.
- Patients with psycological problem or unconsciousness who cannot tell the disease history and cooperate with medical examinations;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Huashan Hospitallead
Study Sites (12)
Gansu Provincial People's Hospital
Lanzhou, Gansu, China
Heilongjiang Provincial Hospital
Harbin, Heilongjinag, 1500036, China
People's Hospital of Inner Mongolia Autonomous Region
Hohhot, Inner Mongolia, China
The First Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, China
Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Shenyang Sixth People's Hospital
Shenyang, Liaoning, China
Shandong University Qilu Hospital
Jinan, Shandong, China
Jining Public Health Center
Jining, Shandong, 0537-7970121, China
Fudan University Affiliated Huashan Hospital
Shanghai, Shanghai Municipality, 200040, China
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
The First People's Hospital of Yunnan Province
Kunming, Yunnan, China
Ruian City People's Hospital
Rui’an, Zhejiang, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Division of Infectious Diseases
Study Record Dates
First Submitted
July 20, 2023
First Posted
July 28, 2023
Study Start
December 1, 2022
Primary Completion
December 1, 2023
Study Completion (Estimated)
December 1, 2027
Last Updated
July 28, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share